Skip to content
Disclosery

MACKENZIE FINANCIAL CORP: ZYME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MACKENZIE FINANCIAL CORP on ZYME, newest first. How the timeline and the estimate are built.

MACKENZIE FINANCIAL CORP held 87,745 ZYME shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 87,745 shares
    Change vs previous 13F +5,019 shares

    <0.01% of the 13F portfolio, value $2,293,654.

    13F-HR 0001062993-26-004254 filed by MACKENZIE FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 82,726 shares
    Change vs previous 13F +37,266 shares

    <0.01% of the 13F portfolio, value $2,071,459.

    13F-HR 0001062993-26-002560 filed by MACKENZIE FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 45,460 shares
    Change vs previous 13F -10,917 shares

    <0.01% of the 13F portfolio, value $1,204,135.

    13F-HR 0001062993-26-001020 filed by MACKENZIE FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 56,377 shares
    Change vs previous 13F +35,022 shares

    <0.01% of the 13F portfolio, value $962,919.

    13F-HR 0001062993-25-016707 filed by MACKENZIE FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 21,355 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $268,005.

    13F-HR 0001062993-25-014242 filed by MACKENZIE FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).